Caveolin-1 is Required for TGF-β-induced Transactivation of the EGF Receptor Pathway in Hepatocytes Through the Activation of the Metalloprotease TACE/ADAM17
Overview
General Medicine
Authors
Affiliations
Transforming growth factor-beta (TGF-β) plays a dual role in hepatocytes, inducing both pro- and anti-apoptotic responses, whose balance decides cell fate. Survival signals are mediated by the epidermal growth factor receptor (EGFR) pathway, which is activated by TGF-β in these cells. Caveolin-1 (Cav1) is a structural protein of caveolae linked to TGF-β receptors trafficking and signaling. Previous results have indicated that in hepatocytes, Cav1 is required for TGF-β-induced anti-apoptotic signals, but the molecular mechanism is not fully understood yet. In this work, we show that immortalized Cav1(-/-) hepatocytes were more sensitive to the pro-apoptotic effects induced by TGF-β, showing a higher activation of caspase-3, higher decrease in cell viability and prolonged increase through time of intracellular reactive oxygen species (ROS). These results were coincident with attenuation of TGF-β-induced survival signals in Cav1(-/-) hepatocytes, such as AKT and ERK1/2 phosphorylation and NFκ-B activation. Transactivation of the EGFR pathway by TGF-β was impaired in Cav1(-/-) hepatocytes, which correlated with lack of activation of TACE/ADAM17, the metalloprotease responsible for the shedding of EGFR ligands. Reconstitution of Cav1 in Cav1(-/-) hepatocytes rescued wild-type phenotype features, both in terms of EGFR transactivation and TACE/ADAM17 activation. TACE/ADAM17 was localized in detergent-resistant membrane (DRM) fractions in Cav1(+/+) cells, which was not the case in Cav1(-/-) cells. Disorganization of lipid rafts after treatment with cholesterol-binding agents caused loss of TACE/ADAM17 activation after TGF-β treatment. In conclusion, in hepatocytes, Cav1 is required for TGF-β-mediated activation of the metalloprotease TACE/ADAM17 that is responsible for shedding of EGFR ligands and activation of the EGFR pathway, which counteracts the TGF-β pro-apoptotic effects. Therefore, Cav1 contributes to the pro-tumorigenic effects of TGF-β in liver cancer cells.
Proactive and reactive roles of TGF-β in cancer.
Kuburich N, Sabapathy T, Demestichas B, Maddela J, den Hollander P, Mani S Semin Cancer Biol. 2023; 95:120-139.
PMID: 37572731 PMC: 10530624. DOI: 10.1016/j.semcancer.2023.08.002.
Muller M, Saunders C, Senftleben A, Heidbuechel J, Halwachs B, Bolik J Cells. 2022; 11(17).
PMID: 36078095 PMC: 9454446. DOI: 10.3390/cells11172683.
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin.
Spaan A, Neehus A, Laplantine E, Staels F, Ogishi M, Seeleuthner Y Science. 2022; 376(6599):eabm6380.
PMID: 35587511 PMC: 9233084. DOI: 10.1126/science.abm6380.
Comparative Metabolomics and Proteomics Reveal Targets Hypoxia-Related Signaling Pathways of .
Xu J, Yu X, Ye H, Gao S, Deng N, Lu Y Front Immunol. 2022; 12:825358.
PMID: 35095928 PMC: 8793131. DOI: 10.3389/fimmu.2021.825358.
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease.
Herranz-Iturbide M, Penuelas-Haro I, Espinosa-Sotelo R, Bertran E, Fabregat I Cells. 2021; 10(9).
PMID: 34571961 PMC: 8470857. DOI: 10.3390/cells10092312.